BIOMUNE
Live / Registered — Registered and renewed (as of 03 Jan 2024)
What this means for you
Registered since 07 Jan 2003. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jan 2023).
Record
- Serial number
- 74606070
- Registration number
- 2670683
- Mark type
- Word mark
- Filed
- 14 Nov 1994
- Published for opposition
- 15 Oct 2002
- Registered
- 07 Jan 2003
- Next maintenance due
- 07 Jan 2023
- Attorney of record
- Ben Natter
Goods and services
- Class 005 — Pharmaceuticals: house mark for a full line of veterinary vaccines, bacterins, antitoxins and diagnostic preparations for veterinary use
- Class 040 — Treatment of materials: [ custom manufacture of vaccines for veterinary use ]
- Class 042 — Scientific and technological services: [ laboratory services for identifying problem microorganisms in the avian and poultry field and development of custom vaccines ]
Owner
- BIOMUNE COMPANY, LENEXA, KS, US
- Biomune Company, Lenexa, KS, US
- Biomune Company, Lenexa, KS, US
- Biomune Company, Lenexa, KS, US
Prior registrations
Prosecution history
- 10 Jan 2024 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 03 Jan 2024 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 03 Jan 2024 — REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
- 03 Jan 2024 — REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
- 03 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jul 2023 — TEAS SECTION 8 & 9 RECEIVED
- 03 Jun 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Jun 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Jun 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Jun 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Jun 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Jun 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Jan 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Jan 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED